Cellectis Monthly Share Capital Update
Analysis based on 6 articles · First reported Jun 03, 2026 · Last updated Jul 02, 2026
The market impact is minimal as these are routine monthly disclosures by Cellectis, providing transparency on its share capital and voting rights. Investors may use this information for compliance and minor adjustments in their valuation models.
Cellectis, a publicly traded company on Euronext Paris, has released its monthly updates on the total number of shares in its capital and voting rights for May 31, 2026, and June 30, 2026. As of June 30, 2026, Cellectis reported 100,698,158 shares and 105,551,650 voting rights. For May 31, 2026, the company reported 100,691,658 shares and 106,134,467 voting rights. These disclosures are made in accordance with Article 223-16 of the General Regulation of the Netherlands — Dutch Authority for the Financial Markets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard